Corporate Finance
Marina Bozilenko



Head of Biotechnology and Pharma
+1.617.235.7523
MBozilenko@williamblair.com
Boston
Education University of Chicago, MA
University of Chicago, BA
Languages Spoken Russian
French
Joined William Blair & Company 2010
Other Experience SMD Bear Stearns
MD Bank of America Securities
MD Vector Securities
Board Membership Olema Pharmaceuticals, Inc.
Community Involvement University of Chicago, Dean's Visiting Committee
Notable Transactions
  • Amgen - Convertible Debt Offering

  • Celgene - follow-on offering

  • Idenix - strategic alliance with Novartis AG

  • Triangle Pharmaceuticals - sale to Gilead

  • F. Hoffman-La Roche Ltd. - acquisition of PCR technology

Back to alphabetical team list
Statement of Financial Condition | NMS Rule 605 and Rule 606 Information | Site Map | Privacy and Security
Copyright © 2010 William Blair & Company, L.L.C.
"William Blair & Company", "William Blair & Company (script)", "R*Docs", and "A Tradition of Growth" are registered trademarks of William Blair & Company, L.L.C.
This site and the content accessible herein are subject to certain disclaimers.